STK32C activated IL-6/JAK2/STAT3 signaling and promoted tumor angiogenesis. Zhang X, Jin M, Chu Y, Liu F, et al. Br J Cancer 2026;134:60-71.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang X, Jin M, Chu Y, Liu F, et al. STK32C activated IL-6/JAK2/STAT3 signaling and promoted tumor angiogenesis. Br J Cancer 2026;134:60-71.
PMID: 41139165